CPU Frontier | Latest Research Progress Episode 6

Release date:2019-02-01  Release:主页英文版






Transforming   Weakness into Strength: PhotothermalTherapyInduced Inflammation Enhanced Cytopharmaceutical   Chemotherapy as a Combination Anticancer Treatment

Advanced   Materials(IF 21.950)

Zhang Can, Su   Zhi Gui, Zhang Lei, Zhang Ying

School of   Sciences, ZHANG Can Team

A dual   targeting dendrimer-mediated siRNA delivery system for effective gene   silencing in cancer therapy

Journal of the American Chemical Society (IF 14.357)

Dong Yi Wen, Peng Ling, Liu Xiao Xuan

School of Sciences, PENG Ling & LIU XiaoXuan Team

Discovery of   a Potent Grp94 Selective Inhibitor with Anti-inflammatory Efficacy in a Mouse   Model of Ulcerative Colitis

Journal of   Medicinal Chemistry (IF 6.253)

Jiang Fen, You   Qi -Dong, Xu Xiao-Li

School of   Pharmacy, ,YOU QiDong, XU XiaoLi Team

Discovery of   Non-Quinone Substrates for NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as   Effective Intracellular ROS Generators for the Treatment of Drug-Resistant   Non-Small Cell Lung Cancer

Journal of Medicinal Chemistry (IF: 6.253)

Wu Xing-Sen, Zhang Xiao-Jin, You Qi-Dong

School of Sciences, YOU QiDong & ZHANG XiaoJin Team

The   deubiquitinase CYLD is a specific checkpoint of the STING antivirial   signaling pathway

PLoS   Pathogens(IF 6.158)

Wang Chen, Chen   Zheng-Jun

School of   Life Sciences, WANG Chen Team

A   drug-delivering-drug strategy for combined treatment of metastatic breast   cancer

Nanomedicine: Nanotechnology, Biology, and Medicine

Yi Li Fang, He Wei, Xiao Qing Qing